| Citation: |
ZHAO Ran, SHI Ruihua. Diagnostic Value of Peripheral Blood NLR and PLR in Gastrointestinal Pancreatic Neuroendocrine Neoplasm[J]. Cancer Research on Prevention and Treatment, 2019, 46(8): 724-728. DOI: 10.3971/j.issn.1000-8578.2019.19.0009
|
To explore the diagnostic value of peripheral blood NLR and PLR in gastrointestinal pancreatic neuroendocrine neoplasm.
Blood cell analyzer was used to detect peripheral blood cell parameters of 95 cases pathologically diagnosed as GEP-NENs. NLR and PLR were calculated respectively, and 97 cases of chronic gastritis and 106 cases of healthy physical examination were taken as the control. ROC curve was used to analyze the diagnostic value of NLR/PLR for GEP-NENs and seek the cut-off value. We analyzed the relationship between NLR/PLR and clinicopathological features.
(1) The values of NLR (2.51±1.32) and PLR (148.26±72.99) in GEP-NENs group were significantly higher than those in chronic gastritis group and control group(P < 0.01). (2) Area under the ROC curve for NLR and PLR were 0.674 and 0.671, the cut-off value were 2.24 and 156.85, the sensitivity were 48% and 41%, and the specificity were 86% and 89%, respectively. (3) There was no apparent correlation between NLR/PLR and pathological grade(P > 0.05). According to the cut-off value, the GEP-NENs patients were divided into high value group and low value group, the chi-square test results showed no correlation between NLR/PLR values and clinicopathological parameters of GEP-NENs patients (P > 0.05).
Peripheral blood NLR and PLR values are significantly increased in GEP-NENs patients, however, the diagnostic accuracy and positive rate of GEP-NENs are relatively low, without significant correlation with the severity or progression of disease.
| [1] |
Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971[J]. Am J Gastroenterol, 2010, 105(12): 2563-2569. doi: 10.1038/ajg.2010.341
|
| [2] |
Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States[J]. JAMA Oncol, 2017, 3(10): 1335-1342. doi: 10.1001/jamaoncol.2017.0589
|
| [3] |
Guo LJ, Wang CH, Tang CW. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution[J]. Asia Pac J Clin Oncol, 2016, 12(3): 284-288. doi: 10.1111/ajco.12498
|
| [4] |
罗文浩, 吴小冉, 历周.胃肠胰神经内分泌肿瘤的最新共识[J].肿瘤防治研究, 2018, 45(1): 41-46. doi: 10.3971/j.issn.1000-8578.2018.17.0491
Luo WH, Wu XR, Li Z. Research progress of gastroenteropancreatic neuroendocrine neoplasm[J]. Zhong Liu Fang Zhi Yan Jiu, 2018, 45(1): 41-46. doi: 10.3971/j.issn.1000-8578.2018.17.0491
|
| [5] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474. doi: 10.1245/s10434-010-0985-4
|
| [6] |
Bosman F, Carneiro F, Hruban R, et al. WHO Classification of Tumors of the Digestive System[M]. Lyon, France: IARC Press, 2010.
|
| [7] |
Azab B, Mohammad F, Shah N, et al. The value of the pretreatment neutrophil lymphocyte ratio vs. Platelet lymphocyte ratio in predicting the long-term survival in eolorectal cancer[J]. Cancer Biomark, 2014, 14(5): 303-312. doi: 10.3233/CBM-140416
|
| [8] |
Zhou Y, Li D, Lin Y, et al. Pretreatment hematologic markers as prognostic predictors of Gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis[J]. Onco Targets Ther, 2018, 11: 2489-2496. doi: 10.2147/OTT.S152657
|
| [9] |
Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients[J]. Ann Surg Oncol, 2012, 19(1): 217-224. doi: 10.1245/s10434-011-1814-0
|
| [10] |
Baniyash M, Sade-Feldman M, Kanterman J. Chronic inflammation and cancer: suppressing the suppressors[J]. Cancer Immunol Immunother, 2014, 63(1): 11-20. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_3086374
|
| [11] |
Shen M, Hu P, Donskov F, et al. Tumor-associated neutrophils as a new prognostic factor in cancer:a systematic review and meta-analysis[J]. PLoS One, 2014, 9(6): e98259. doi: 10.1371/journal.pone.0098259
|
| [12] |
Sionov RV, Assis S, Gershkovitz M, et al. Isolation and characterization of neutrophils with anti-tumor properties[J]. J Vis Exp, 2015, 19(100): e52933. http://cn.bing.com/academic/profile?id=04711090761c795bf0ba6bb95e854c8b&encoded=0&v=paper_preview&mkt=zh-cn
|
| [13] |
王爱云, 曹玉珠, 韦忠红, 等.血小板促进肿瘤生长与转移机制研究进展[J].中国药理学通报, 2018, 34(8): 1045-1049. doi: 10.3969/j.issn.1001-1978.2018.08.003
Wang AY, Cao YZ, Wei ZH, et al. Platelets promoting tumor growth and metastasis[J]. Zhongguo Yao Li Xue Tong Bao, 2018, 34(8): 1045-1049. doi: 10.3969/j.issn.1001-1978.2018.08.003
|
| [14] |
马欣俐, 赵文毅, 庄淳, 等. 119例胃肠道神经内分泌肿瘤的病理分型及预后危险因素分析[J].中华胃肠外科杂志, 2017, 20(9): 997-1001. doi: 10.3760/cma.j.issn.1671-0274.2017.09.009
Ma XL, Zhao WY, Zhuang C, et al. Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2017, 20(9): 997-1001. doi: 10.3760/cma.j.issn.1671-0274.2017.09.009
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: